Legal & General Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $750K | Buy |
66,825
+7,356
| +12% | +$82.6K | ﹤0.01% | 2320 |
|
|
2025
Q1 | $272K | Sell |
59,469
-4,957
| -8% | -$22.7K | ﹤0.01% | 2563 |
|
|
2024
Q4 | $363K | Buy |
64,426
+11,628
| +22% | +$65.6K | ﹤0.01% | 2565 |
|
|
2024
Q3 | $256K | Hold |
52,798
| – | – | ﹤0.01% | 2640 |
|
|
2024
Q2 | $258K | Sell |
52,798
-1,056
| -2% | -$5.15K | ﹤0.01% | 2633 |
|
|
2024
Q1 | $715K | Buy |
53,854
+2,124
| +4% | +$28.2K | ﹤0.01% | 2305 |
|
|
2023
Q4 | $721K | Buy |
51,730
+12,880
| +33% | +$180K | ﹤0.01% | 2324 |
|
|
2023
Q3 | $515K | Buy |
38,850
+5,125
| +15% | +$68K | ﹤0.01% | 2422 |
|
|
2023
Q2 | $632K | Buy |
33,725
+19,641
| +139% | +$368K | ﹤0.01% | 2384 |
|
|
2023
Q1 | $203K | Buy |
14,084
+814
| +6% | +$11.7K | ﹤0.01% | 2583 |
|
|
2022
Q4 | $257K | Buy |
13,270
+567
| +4% | +$11K | ﹤0.01% | 2520 |
|
|
2022
Q3 | $437K | Buy |
12,703
+4,918
| +63% | +$169K | ﹤0.01% | 2377 |
|
|
2022
Q2 | $119K | Buy |
7,785
+252
| +3% | +$3.85K | ﹤0.01% | 2805 |
|
|
2022
Q1 | $172K | Buy |
7,533
+1,993
| +36% | +$45.5K | ﹤0.01% | 2723 |
|
|
2021
Q4 | $204K | Buy |
5,540
+4,054
| +273% | +$149K | ﹤0.01% | 2718 |
|
|
2021
Q3 | $70K | Buy |
+1,486
| New | +$70K | ﹤0.01% | 2909 |
|